Hypothesis

Germline cells sustain telomere length and epigenetic youth through constitutive TERT expression, specialized telomere‑directed base excision repair, and intergenerational reprogramming. Somatic B cells lack these safeguards, causing telomere attrition, oxidative telomere damage, and accumulation of age‑associated epigenetic marks that together curtail activation‑induced deaminase (AID)–driven somatic hypermutation (SHM) in germinal centers. We propose that transiently imparting germline‑grade telomere maintenance and epigenetic reset to aging B cells will restore their mutagenic capacity and preserve repertoire diversity.

Mechanistic basis

1. Telomerase boost – Inducible TERT expression (e.g., via a tamoxifen‑responsive ERT2‑TERT construct) in germinal center B cells will counteract replicative telomere shortening that limits proliferative cycles 2.
2. Telomere‑specific BER enhancement – Overexpressing telomere‑binding proteins such as TRF2 or supplementing with a telomere‑targeted antioxidant (e.g., MitoTEMPO conjugated to a telomere‑binding peptide) will shelter G‑rich repeats from oxidative lesions, mirroring germline shelterin‑regulated repair 3.
3. Epigenetic reset – Short‑term exposure to vitamin C (a Tet‑dependent demethylase cofactor) combined with a low‑dose HDAC inhibitor (e.g., entinostat) will erase age‑associated methylation marks and reactivate the TERT promoter, replicating the germline reprogramming wave 4.

Predicted outcome

If the germline‑like maintenance program is sufficient, aged mice receiving the combined intervention should show:

• Increased telomere length in sorted germinal center B cells (Q‑FISH).
• Reduced telomere‑associated DNA damage foci (γH2AX/TRF2 colocalization).
• Restoration of AID expression levels to youthful levels despite inflammatory milieu.
• Elevated SHM frequency, especially replacement mutations in complementarity‑determining regions 5.
• Broadened CDR3 junctional diversity and higher affinity antigen‑specific antibodies after immunization.

Experimental design (testable & falsifiable)

• Groups: young (3‑mo) controls, aged (20‑mo) untreated, aged treated with inducible TERT alone, aged treated with telomere‑BER enhancer alone, aged treated with epigenetic reset alone, aged receiving the triple combination.
• Readouts (at day 7 post‑immunization with NP‑OVA): telomere length, γH2AX/TRF2 foci, AID mRNA/protein, SHM sequencing of IgG1 V regions, affinity ELISA.
• Falsification: If the triple combination fails to produce a statistically significant increase in SHM frequency or affinity relative to aged untreated, the hypothesis that germline‑grade telomere and epigenetic maintenance can rescue B cell mutagenicity is refuted.

Broader implication

Demonstrating that somatic lymphocytes can be endowed with a germline‑style editing budget would shift the paradigm from merely boosting telomerase to a coordinated telomere‑repair‑epigenetic axis, opening translational avenues for vaccine efficacy in the elderly.